Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Leftwich currently holds 4,000 shares of Calidi Biotherapeutics, Inc. (CLDI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Leftwich has been a net buyer of CLDI stock. They have purchased $250.0K and sold $0 worth of shares.
Scott Leftwich's most recent insider trade was on Aug 17, 2026, when they sold 4,000 shares at $0.00 per share.
Scott Leftwich serves as Executive at Calidi Biotherapeutics, Inc. (CLDI). They have executed 7 insider transactions totaling $250.0K over their tenure at the company.
Scott Leftwich holds the position of Executive at Calidi Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Scott Leftwich has shown a buying trading pattern, with $250.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Scott Leftwich was on Aug 21, 2025, when they purchased $250.0K worth of CLDI shares. This transaction involved 125,000 shares at $2.00 per share.
Scott Leftwich currently owns 4,000 shares of Calidi Biotherapeutics, Inc. (CLDI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Leftwich's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Leftwich has 7 Form 4 filings on record as an insider at Calidi Biotherapeutics, Inc..
Set alerts for Scott Leftwich and 40,000+ other insiders.